These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8504514)

  • 1. Factors contributing to increased vascular fibrinolytic activity in mongrel dogs.
    Lang IM; Marsh JJ; Konopka RG; Olman MA; Binder BR; Moser KM; Schleef RR
    Circulation; 1993 Jun; 87(6):1990-2000. PubMed ID: 8504514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Habutobin releases plasminogen activator (U-PA) from bovine pulmonary artery endothelial cells.
    Sunagawa M; Hanashiro K; Nakamura M; Kosugi T
    Toxicon; 1996 Jun; 34(6):691-9. PubMed ID: 8817813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic system of cultured rabbit aortic endothelial cells.
    al-Azhary DB; Wojta J; Binder BR
    Thromb Res; 1994 Sep; 75(5):559-68. PubMed ID: 7992256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolytic activity and species of plasminogen activator in human tears.
    Hayashi K; Sueishi K
    Exp Eye Res; 1988 Feb; 46(2):131-7. PubMed ID: 3127227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.
    Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ
    Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of single-chain urokinase-type plasminogen activator by platelet-associated plasminogen: a mechanism for stimulation of fibrinolysis by platelets.
    Baeten KM; Richard MC; Kanse SM; Mutch NJ; Degen JL; Booth NA
    J Thromb Haemost; 2010 Jun; 8(6):1313-22. PubMed ID: 20180903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
    Kawakami K; Takahashi A; Yoshimoto T
    No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M; Lijnen HR; Keber D; Collen D
    Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of endothelial cells fibrinolytic activity by platelets.
    Menashi S; He L; Soria C; Soria J; Thomaidis A; Legrand Y
    Thromb Haemost; 1991 Jan; 65(1):77-81. PubMed ID: 2024242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction.
    Kunitada S; FitzGerald GA; Fitzgerald DJ
    Blood; 1992 Mar; 79(6):1420-7. PubMed ID: 1547340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.
    Dong Q; Zhou MH; Subbarao V; Ts'ao CH
    Br J Exp Pathol; 1988 Oct; 69(5):685-95. PubMed ID: 3143395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolism.
    Reilly CF; Fujita T; Hutzelmann JE; Mayer EJ; Shebuski RJ
    Circulation; 1991 Jul; 84(1):287-92. PubMed ID: 1905594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin.
    Dewerchin M; Lijnen HR; Van Hoef B; De Cock F; Collen D
    Eur J Biochem; 1989 Oct; 185(1):141-9. PubMed ID: 2530085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the pericellular fibrinolytic system in angiogenesis.
    Fukao H; Ueshima S; Okada K; Matsuo O
    Jpn J Physiol; 1997 Apr; 47(2):161-71. PubMed ID: 9201545
    [No Abstract]   [Full Text] [Related]  

  • 17. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J; Yu M; Ru B
    Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells.
    Wileman SM; Booth NA; Moore N; Redmill B; Forrester JV; Knott RM
    Br J Ophthalmol; 2000 Apr; 84(4):417-22. PubMed ID: 10729302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of human tissue plasminogen activator (t-PA) to blood clots and clot-lytic activity of clot-bound t-PA.
    Kimata H; Nakajima K; Yamamoto S; Hasegawa A
    J Pharmacobiodyn; 1990 Dec; 13(12):745-50. PubMed ID: 2129127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.